AvailOm® Manufacturer in India | Mediocon Inc.

AvailOm® – Advanced Omega-3 Lysine Complex for Nutraceutical Formulations

Product Overview

AvailOm® is a branded omega-3 lysine complex developed by Evonik for use in dietary supplement and nutraceutical applications. Designed as a powder-based ingredient platform, AvailOm® offers formulators an alternative to conventional liquid omega-3 oils when developing suitable solid dosage forms and specialized nutritional products. Its composition combines omega-3 fatty acids, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), with the essential amino acid L-lysine.

Omega-3 fatty acids are widely used in nutritional formulations because of their established role in human nutrition. EPA and DHA are long-chain omega-3 fatty acids that are commonly incorporated into dietary supplements and other nutritional products. L-lysine is an essential amino acid that the human body cannot produce in sufficient quantities and therefore must obtain through dietary sources. The combination of these components in a specialized ingredient platform provides product developers with an additional option when designing omega-3-based formulations.

The exact composition, concentration, physical characteristics, and technical performance of AvailOm® depend on the specific grade and its current manufacturer documentation. Product developers should consult the relevant technical data sheet and certificate of analysis before selecting the ingredient for commercial manufacturing.

Key Features of AvailOm®

AvailOm® is designed to support the development of omega-3 nutritional products that require a powder-based ingredient. Its potential formulation advantages include convenient handling, compatibility with suitable solid dosage-form manufacturing processes, and the ability to incorporate EPA and DHA into selected supplement concepts.

The powder format may be useful for manufacturers developing tablets and other appropriate nutritional dosage forms. Actual processing performance depends on the formulation, equipment, manufacturing conditions, and the specifications of the selected ingredient grade.

Key features include:

• Omega-3 ingredient platform: Designed for formulations containing EPA and DHA.
• L-lysine complex: Combines omega-3 fatty acids with L-lysine as part of the branded ingredient composition.
• Powder-based format: Offers an alternative to conventional liquid oil ingredients in suitable applications.
• Nutraceutical formulation potential: Intended for use by qualified supplement and nutritional product manufacturers.
• Technical documentation: Grade-specific specifications should be obtained from the manufacturer to support product development and quality assurance.
• Formulation flexibility: May support selected solid dosage-form concepts, subject to compatibility and processing validation.

These features should be assessed against the current documentation for the exact AvailOm® grade being sourced.

Understanding EPA and DHA

EPA and DHA are long-chain omega-3 polyunsaturated fatty acids commonly used in nutritional supplements. EPA is associated with several physiological processes, while DHA is an important structural component of cell membranes and is particularly abundant in the brain and retina.

Both fatty acids are important considerations when developing omega-3 supplements